takisbiotech
Menu
Close
Company
About Us
Our Team
Careers
Our Services
Vaccines & Preclinical Immunology
Predictive Models
Monoclonal Antibodies
Recombinant Proteins
Facilities
BSL-3
GMP
Research
Funded Projects
Internal Research
Papers
Congresses
News
Contact Us
Company
About Us
Our Team
Careers
Our Services
Vaccines & Preclinical Immunology
Predictive Models
Monoclonal Antibodies
Recombinant Proteins
Facilities
BSL-3
GMP
Research
Funded Projects
Internal Research
Papers
Congresses
News
Contact Us
Company news
Stay updated with Takis latest news!
authorization as a facility user for animal experimentation for our recently acquired BSL-3 facility
May 6, 2024
|
News
|
CEO Luigi Aurisicchio attended the 4th Consortium Meeting of the MIRIA EU Project in Prague
May 2, 2024
|
News
|
Workshop on Autologous DNA-Based Antibody Production
April 26, 2024
|
News
|
Building a ballon tower was more challenging than expected… but it was a great experience to fine-tune our goal-setting skills!
April 5, 2024
|
News
|
We are thrilled to announce a new initiative promoted by Takis and Vitares and involving Largo Brodolini High School in Pomezia
March 25, 2024
|
News
|
Conference hosted by Sapienza Università di Roma as part of the mid-term date of the Roma Technopole project
March 19, 2024
|
News
|
Emanuele Marra, our COO, has been elected to the board of directors of the pharmaceutical and biomedical section of Unindustria
March 7, 2024
|
News
|
The book “Il Destino in una Parola”, written by our own Erika Salvatori and Emanuele Marra, in collaboration with Labozeta SpA
February 22, 2024
|
News
|
Dynamics of humoral and cellular response to three doses of the anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects
February 6, 2024
|
News
|
1
2
3
4
